Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

18.32
BATS BZX Real-Time Price
As of 12:19pm ET
 +0.40 / +2.23%
Today’s Change
3.55
Today|||52-Week Range
19.30
+22.87%
Year-to-Date
Better Buy: Exelixis, Inc. vs. Novartis
11:49am / MotleyFool.com - Paid Partner Content
4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal
Jan 10 / Zacks.com - Paid Partner Content
Top Performing Contest Portfolios from 2016
Jan 17 / GuruFocus News - Paid Partner Content
Why Exelixis, Inc. Stock Zoomed Higher Today
Jan 09 / MotleyFool.com - Paid Partner Content
After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next
Jan 10 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close17.92
Today’s open18.08
Day’s range18.08 - 18.62
Volume138,912
Average volume (3 months)6,541,323
Market cap$5.1B
Dividend yield--
Data as of 12:19pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+45.86%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC-0.12-0.15%
CRLCharles River Labora...-0.49-0.61%
PRXLPAREXEL Internationa...-0.67-0.96%
PRAHPRA Health Sciences ...-0.29-0.53%
Data as of 12:17pm ET, 01/23/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs